Table 1.
Correlation between circC16orf62 expression and clinicopathological characteristics of HCC patients.
| Clinical epidemiology and clinicopathologic feature | circC16orf62 | p value | ||
|---|---|---|---|---|
| High | Low expression | |||
| All cases | 56 | 32 | ||
| Age | ||||
| ≤50 | 21 | 17 | 0.183 | |
| >50 | 35 | 15 | ||
| Gender | ||||
| Male | 31 | 12 | 0.125 | |
| Female | 25 | 20 | ||
| Diameter of tumor | ||||
| ≤4 | 25 | 23 | 0.016* | |
| >4 | 31 | 9 | ||
| HBV virus infection | ||||
| Negative | 24 | 18 | 0.271 | |
| Positive | 32 | 14 | ||
| Cirrhosis | ||||
| Negative | 16 | 11 | 0.634 | |
| Positive | 40 | 21 | ||
| Distant metastasis | ||||
| Negative | 45 | 27 | 0.777 | |
| Positive | 11 | 5 | ||
| Lymph node metastasis | ||||
| Negative | 39 | 29 | 0.033* | |
| Positive | 17 | 3 | ||
| TNM stage | ||||
| I/II | 42 | 27 | 0.421 | |
| III/IV | 14 | 5 | ||
*p values that are statistically significant are shown in bold.